Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Olopatadine |
| Active Ingredient: | Olopatadine hydrochloride 1.11mg/mL equivalent to olopatadine 1.0mg/mL |
| Dosage Form: | Eye drops, solution |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | FDC Limited, Aurangabad, India |
| Product: | RiaSTAP |
| Active Ingredient: | Fibrinogen 900mg-1300mg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | CSL Behring (NZ) Limited |
| Manufacturer: | CSL Behring GmbH, Marburg, Germany |
Dated this 25th day of November 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).